Company / Revenue per Share
Tarsus Pharmaceuticals, Inc. Revenue per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$11.77
FY2025
5-year range
$0.65 / $11.77
FY2021-FY2025
Trend
+120.1%
vs FY2024
Sector context
#42 of 154
Health Care
What the data says
At $11.77, Tarsus Pharmaceuticals, Inc.'s revenue per share ranks #42 of 154 in the Health Care sector. Improved from $0.65 to $11.77 over the past 2 years.
Based on SEC 10-K filings.
11.77 in FY2025 with a 3-year CAGR of +62.3%.
Improved from $0.65 to $11.77 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +62.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#42 of 154 in Health CareTop 27% of 154This company $11.77 Sector average $15.09
▼
-22.0% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 120.1% year-over-year.
- Ranks #42 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.77 | +120.1% |
| FY2024 | $5.35 | +718.4% |
| FY2023 | $0.65 | -76.3% |
| FY2022 | $2.76 | -1.8% |
| FY2021 | $2.81 | - |
| FY2020 | $0.00 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026